z-logo
Premium
The Development of Antimicrobial α‐AApeptides that Suppress Proinflammatory Immune Responses
Author(s) -
Padhee Shruti,
Smith Christina,
Wu Haifan,
Li Yaqiong,
Manoj Namitha,
Qiao Qiao,
Khan Zoya,
Cao Chuanhai,
Yin Hang,
Cai Jianfeng
Publication year - 2014
Publication title -
chembiochem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.05
H-Index - 126
eISSN - 1439-7633
pISSN - 1439-4227
DOI - 10.1002/cbic.201300709
Subject(s) - proinflammatory cytokine , antimicrobial , tlr4 , peptidomimetic , tumor necrosis factor alpha , bacteria , immune system , biology , microbiology and biotechnology , gram negative bacteria , inflammation , chemistry , immunology , biochemistry , peptide , escherichia coli , gene , genetics
Herein we describe the development of a new class of antimicrobial and anti‐inflammatory peptidomimetics: cyclic lipo‐α‐AApeptides. They have potent and broad‐spectrum antibacterial activity against a range of clinically relevant pathogens, including both multidrug‐resistant Gram‐positive and Gram‐negative bacteria. Fluorescence microscopy suggests that cyclic lipo‐α‐AApeptides kill bacteria by disrupting bacterial membranes, possibly through a mechanism similar to that of cationic host‐defense peptides (HDPs). Furthermore, the cyclic lipo‐α‐AApeptide can mimic cationic host‐defense peptides by antagonizing Toll‐like receptor 4 (TLR4) signaling responses and suppressing proinflammatory cytokines such as tumor necrosis factor‐α (TNF‐α). Our results suggest that by mimicking HDPs, cyclic lipo‐α‐AApeptides could emerge as a new class of antibiotic agents that directly kill bacteria, as well as novel antiinflammatory agents that act through immunomodulation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here